Novo Nordisk sees pills capturing over third of GLP-1 obesity market by 2030

Oral weight-loss drugs could account for a third or more of the overall GLP-1 market by 2030, a Novo Nordisk executive said ...

Serena, Simone… and Tom Brady: Star athletes are now promoting GLP-1s — what it means for your weight loss

There’s no sign of GLP-1s slowing down anytime soon, especially now that they have the support of top-notch athletes.

Serena Williams on Taking a GLP-1: ‘I Feel Like I’m Back'

So I wasn’t surprised when Williams was hit with a whole lot of “how dare you”—as Oprah Winfrey put it on the January 13 ...
Everyday Health on MSN

Using GLP-1s for Obesity During Menopause: Benefits and Risks

Learn how GLP-1 medications support weight loss and heart health in perimenopause and postmenopause, plus get tips for ...

Aon's Latest GLP-1 Research Reveals Long-Term Employer Cost Savings and Significant Reductions in Cancer Risk for Women

Aon plc (NYSE: AON), a leading global professional services firm, today released updated findings from its multi-year study of U.S. commercial health claims data, building on its GLP-1 research first ...

Stopping GLP-1 Weight Loss Drugs Leads to Fast Rebound in Weight and Heart Risks, Study Warns

Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to ...

GLP-1 coverage for non-diabetes-related care dropped by Howard Schools

Howard Schools expected health care premiums to increase by 19.5% if GLP-1 coverage continued, leading to an increase of $47 ...

Novo Nordisk sees oral pills capturing over third of GLP-1 market by 2030

Oral weight-loss drugs could make up a third or more of the overall GLP-1 market by 2030, a larger percentage than the ...

Are GLP-1s Actually A Mental Health Drug? New Findings On Mood, Cravings, and Mental Health

What started out as a medication for diabetes and weight loss is offering something quite unexpected for many women. Experts ...